Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical TrialJ. Andrew Bird, A. Wesley Burks, Antonella Cianferoni et al.|The Journal of Allergy and Clinical Immunology In Practice|2017Cited by 200
Shared Genetic Etiology Between Eoe and Other Allergic DiseasesLeah C. Kottyan, Marc E. Rothenberg, Benjamin P. Davis et al.|Journal of Allergy and Clinical Immunology|2015Cited by 1